|
Overview
Company Profile
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE: HDST) in order to allow public participation in the promising field of biotechnology. It serves as a precedent in biotechnology financing - for the first time, public investment is allowed to participate in companies based on IP generated by Israel's foremost medical research center - the Hadassah University Hospital ("Hadassah"), which is responsible for the majority of Israel's hospital-based translational research.
|
Stock Quotes
US ADR listing:
HADSY (OTCBB)
|
Press Releases
|
Investor Contact
Phone: + 972-2-677-8757
Fax: + 972-2-643-7712
Email: info@hbl.co.il
|
|
|
